A broadly neutralizing human monoclonal antibody is effective against H7N9. - Wikidata - awgldk - TriplyDB

A broadly neutralizing human monoclonal antibody is effective against H7N9.

A broadly neutralizing human monoclonal antibody is effective against H7N9.

http://www.wikidata.org/entity/Q30378035

about

A new reassortment of influenza A (H7N9) virus causing human infection in Beijing, 2014 Universal influenza virus vaccines and therapeutic antibodies.Investigational hemagglutinin-targeted influenza virus inhibitors.Novel universal influenza virus vaccine approaches Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo.Iminosugars: Promising therapeutics for influenza infection.The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome.Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A Outbreaks A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release.H7N9 avian influenza A virus in China: a short report on its circulation, drug resistant mutants and novel antiviral drugs.A Structural and Mathematical Modeling Analysis of the Likelihood of Antibody-Dependent Enhancement in Influenza.AChiralPentagonalPolyhedralFramework forCharacterizingVirusCapsidStructures.Antiviral therapy for respiratory viral infections in immunocompromised patients.One Against All: A Broadly Influenza Neutralizing Man-made Monoclonal Antibody Passes Phase I.Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses.A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody.A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies The continual threat of influenza virus infections at the human-animal interface: What is new from a one health perspective?

P2860

Q28602120-EAB60377-B274-4456-9576-FE5E2F1AF600 Q30151337-DF0F9AAE-567E-460D-A63E-F11D7C036ED4 Q30240175-E97E8C57-2E55-4DF2-9262-59C657D0DD2F Q30385071-B37278BC-7096-43FA-AF13-D7017BBA3490 Q30392944-45AB1F5B-F98A-40E6-B492-E21ECDD69A0B Q30571702-3AC22177-1D20-4819-956D-39AED816FD52 Q33795341-69E09E2D-CE08-45BA-A4E5-B103A9F37CC3 Q36730084-51819324-6837-42A4-B1DA-E49DD49C84D1 Q36754078-802C3F61-179E-4A6E-852A-C021478FC8A0 Q37714300-AD4533A9-EFF2-4262-A619-2D731AC1F6C9 Q38686514-DC454DA4-1F8F-4156-9AC0-45D3AB15B6EA Q38983251-DE001545-0109-45E6-9FFC-B97A55EC8F48 Q39017347-4A739477-DE1A-462C-9795-8E25E7DFC315 Q39076394-7793EE07-174D-40A9-B24C-C1685263249B Q39762082-CBD6EB0D-E3EE-45A7-AAFC-D5575B4A245B Q47549109-11296AC1-4E50-4E5C-9858-59034900357D Q52659466-0DC8A7D0-3D73-473C-909E-4DAF50A095D7 Q56999052-6EA416E9-6199-4055-B1D3-CF1D28612512 Q57093697-B8AD160B-59EA-4BF6-AD62-7A392E0C5B17

P2860

A broadly neutralizing human monoclonal antibody is effective against H7N9.

http://www.wikidata.org/entity/Q30378035

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

A broadly neutralizing human monoclonal antibody is effective against H7N9.

@ast

A broadly neutralizing human monoclonal antibody is effective against H7N9.

@en

type

label

A broadly neutralizing human monoclonal antibody is effective against H7N9.

@ast

A broadly neutralizing human monoclonal antibody is effective against H7N9.

@en

prefLabel

A broadly neutralizing human monoclonal antibody is effective against H7N9.

@ast

A broadly neutralizing human monoclonal antibody is effective against H7N9.

@en

P1433

Q30378035-69B2A989-CBFD-4F09-B74D-4A5C4017BA28

P1476

Q30378035-8A9E7281-CB02-456F-ACDC-F3D9C3EE829F

P2093

Q30378035-17E70095-972D-479D-A066-FF796B02AD04

Q30378035-2DD0B49C-17E7-46BD-B43C-9631447D60D9

Q30378035-2E543C1D-F49E-400E-8C1E-B25F1C089D9F

Q30378035-44AEA5CE-E79F-4392-B421-F1841A3AC9AB

Q30378035-59426CD9-39AD-4215-9F38-DFE9EC0C9BCD

Q30378035-5B5A5077-9DF0-4DB5-B829-2AC867427A52

Q30378035-5FE81E82-D53E-435D-A0A7-0D0233869E25

Q30378035-7C287AA3-E349-4B55-A2ED-5B01C76B12CF

Q30378035-84B21765-F64C-48E8-A5F7-49CF6AC88A18

Q30378035-90834D55-D148-4327-9F59-4CCC7B291D85

P2860

Q30378035-027A5DAB-721E-4289-8871-0E21A1ACA72D

Q30378035-1535C2BE-B201-45D6-9B09-074CDE3645F1

Q30378035-18D29188-5631-4BA7-9F82-D6166A8EA7C1

Q30378035-2427D058-1E0D-457A-AA5C-9089958A257B

Q30378035-28CD4E93-6B30-4413-A72A-94D2D9124B58

Q30378035-2B7F4BB6-56EF-44CE-91A6-3CDC5C4437F8

Q30378035-2BA89AD0-FB6C-40E4-A3A7-4947ED86F526

Q30378035-40E7FE9B-E2E3-4CD7-91B8-5154FAD9AD72

Q30378035-4670BB7A-67E8-4FC8-AB04-88306E511A8C

Q30378035-56D516E2-9AFD-4124-9F61-D52D1D64F353

P304

Q30378035-888BE761-B442-4E98-B504-52377846FFFD

P31

Q30378035-5596BF2E-1663-422E-9C80-245BF1AE053C

P356

Q30378035-47256387-93F3-48BB-AF2F-7E468019DD67

P407

Q30378035-74B5B1FC-64C4-47C1-A975-7C64A341B9E7

P433

Q30378035-4D1A3F8F-30F4-4A1A-8594-B6629E13E6CB

P478

Q30378035-9F403AEC-1307-4B9D-AF69-ECAE5FBB46DD

P50

Q30378035-76AE9835-2640-42DA-B8EF-418EE28D211A

Q30378035-B580C740-5D76-4660-BF1B-6BB630E79FCE

P577

Q30378035-E4828B18-DB32-4D71-BC6B-450248199620

P5875

Q30378035-66784442-856C-423D-B4C9-0FAD0DC4887E

P698

Q30378035-E2697104-CB27-4E12-B006-DFCB86C216EC

P921

Q30378035-BF94ECE9-9B77-4ED1-9738-E129BDD5A9CA

P932

Q30378035-FA0E5C5E-AC4B-4277-B1C3-C0B548A46DE5

P356

PNAS.1502374112

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A broadly neutralizing human monoclonal antibody is effective against H7N9.

@en

P2093

Dale L Barnard

http://www.w3.org/2001/XMLSchema#string

Gerald N Wogan

http://www.w3.org/2001/XMLSchema#string

Gregory J Babcock

http://www.w3.org/2001/XMLSchema#string

James C Delaney

http://www.w3.org/2001/XMLSchema#string

Kannan Tharakaraman

http://www.w3.org/2001/XMLSchema#string

Karthik Viswanathan

http://www.w3.org/2001/XMLSchema#string

Ram Sasisekharan

http://www.w3.org/2001/XMLSchema#string

Susan Sloan

http://www.w3.org/2001/XMLSchema#string

Tyree J Koch

http://www.w3.org/2001/XMLSchema#string

Vidya Subramanian

http://www.w3.org/2001/XMLSchema#string

P2860

A highly conserved neutralizing epitope on group 2 influenza A viruses

Increasing the potency and breadth of an HIV antibody by using structure-based rational design

Mechanisms of hemagglutinin targeted influenza virus neutralization

Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodies

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial

DBA/2 mouse as an animal model for anti-influenza drug efficacy evaluation.

Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model.

Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.

Clinical findings in 111 cases of influenza A (H7N9) virus infection.

P304

10890-10895

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1502374112

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Kristy J Szretter

P577

2015-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281813189

http://www.w3.org/2001/XMLSchema#string

P698

26283346

http://www.w3.org/2001/XMLSchema#string

P921

P932

4568252

http://www.w3.org/2001/XMLSchema#string